Mohammadreza Masjedi1, Elaheh Ainy2, Faried Zayeri3, Rogayeh Paydar4. 1. Department of Pulmonology and Internal Medicine, Control Research Center, Iranian Anti-Tobacco Association, Shadid Behesti University of Medical Sciences, Tehran, Iran. 2. Department of Injury Epidemiology, Safety Promotions and Injury Prevention Research Center of Shadid Behesti University of Medical Sciences, Tehran, Iran. 3. Department of Biostatistics, Proteomics Research Center, Faculty of Paramedical Sciences, Shadid Behesti University of Medical Sciences, Tehran, Iran. 4. Tobacco Control Research Center, Iranian Anti-Tobacco Association, Shadid Behesti University of Medical Sciences, Tehran, Iran.
Abstract
OBJECTIVES: This study conducted in 2016 aimed to assess the prevalence and incidence of asthma and chronic obstructive pulmonary disease (COPD) in the Eastern Mediterranean Region (EMR). MATERIAL AND METHODS: A meta-analysis to evaluate the published research relating to asthma and COPD was conducted using data from 23 EMR Office (EMRO) countries and searching using the web of science, PubMed, SciVerse Scopus, Google scholar, and MEDLINE databases. The keywords entered were all EMRO countries (Afghanistan, Bahrain, Djibouti, Egypt, Islamic republic Iran, Iraq, Jordan, Kuwait, Lebanon, Libyan Arab Jamahiriya, Morocco, Oman, Pakistan, Palestine, Qatar, Saudi Arab, Somalia, Sudan, Syrian Arab Republic, Tunisia, the United Arab Emirates, Yemen republic, and Cyprus) and asthma OR chronic obstructive pulmonary disease (COPD) OR (chronic bronchitis). Our definition of asthma and COPD was according to the World Health Organization (WHO). RESULTS: A total of 92 published articles were identified. The pooled prevalence of asthma and COPD was 9.38 (confidence interval [CI]: 9.20-9.55) and 5.39 (CI: 5.17-5.62), respectively. There were no articles about COPD and asthma in Bahrain and Djibouti; no articles about asthma in Jordan and Libyan Arab Jamahiriya; and no articles about COPD in Afghanistan, Iraq, Oman, Palestine, Somalia, Sudan, and Yemen republic. The highest prevalence of asthma was observed in Kuwait, and the highest prevalence of COPD was observed in Pakistan. CONCLUSION: The EMRO countries have inadequate research and data in the areas of asthma and COPD. More efforts and relevant studies must be conducted to understand the countrywide prevalence and real burden of these diseases.
OBJECTIVES: This study conducted in 2016 aimed to assess the prevalence and incidence of asthma and chronic obstructive pulmonary disease (COPD) in the Eastern Mediterranean Region (EMR). MATERIAL AND METHODS: A meta-analysis to evaluate the published research relating to asthma and COPD was conducted using data from 23 EMR Office (EMRO) countries and searching using the web of science, PubMed, SciVerse Scopus, Google scholar, and MEDLINE databases. The keywords entered were all EMRO countries (Afghanistan, Bahrain, Djibouti, Egypt, Islamic republic Iran, Iraq, Jordan, Kuwait, Lebanon, Libyan Arab Jamahiriya, Morocco, Oman, Pakistan, Palestine, Qatar, Saudi Arab, Somalia, Sudan, Syrian Arab Republic, Tunisia, the United Arab Emirates, Yemen republic, and Cyprus) and asthma OR chronic obstructive pulmonary disease (COPD) OR (chronic bronchitis). Our definition of asthma and COPD was according to the World Health Organization (WHO). RESULTS: A total of 92 published articles were identified. The pooled prevalence of asthma and COPD was 9.38 (confidence interval [CI]: 9.20-9.55) and 5.39 (CI: 5.17-5.62), respectively. There were no articles about COPD and asthma in Bahrain and Djibouti; no articles about asthma in Jordan and Libyan Arab Jamahiriya; and no articles about COPD in Afghanistan, Iraq, Oman, Palestine, Somalia, Sudan, and Yemen republic. The highest prevalence of asthma was observed in Kuwait, and the highest prevalence of COPD was observed in Pakistan. CONCLUSION: The EMRO countries have inadequate research and data in the areas of asthma and COPD. More efforts and relevant studies must be conducted to understand the countrywide prevalence and real burden of these diseases.
Authors: Erik von Elm; Douglas G Altman; Matthias Egger; Stuart J Pocock; Peter C Gøtzsche; Jan P Vandenbroucke Journal: Gac Sanit Date: 2008 Mar-Apr Impact factor: 2.139
Authors: Hager Daldoul; Meriam Denguezli; Anamika Jithoo; Louisa Gnatiuc; Sonia Buist; Peter Burney; Zouhair Tabka; Imed Harrabi Journal: Int J Environ Res Public Health Date: 2013-12-17 Impact factor: 3.390
Authors: Demetris Lamnisos; Maria Moustaki; Ourania Kolokotroni; Huseyin Koksoy; Muharrem Faiz; Kenan Arifoglu; Donald K Milton; Nicos Middleton; Panayiotis K Yiallouros Journal: BMC Public Health Date: 2013-06-16 Impact factor: 3.295
Authors: Richard Kwizera; Joseph Musaazi; David B Meya; William Worodria; Freddie Bwanga; Henry Kajumbula; Stephen J Fowler; Bruce J Kirenga; Robin Gore; David W Denning Journal: PLoS One Date: 2019-05-16 Impact factor: 3.240
Authors: Badr Rashed Al Ghamdi; Emad Abdulkadir Koshak; Hussein Mohammad Ageely; Fakhreldin Mohamed Omer; Nabil Joseph Awadalla; Ahmed A Mahfouz Journal: Ann Thorac Med Date: 2019 Oct-Dec Impact factor: 2.219
Authors: Wadha Alfouzan; Faten Al-Wathiqi; Haya Altawalah; Mohammad Asadzadeh; Ziauddin Khan; David W Denning Journal: J Fungi (Basel) Date: 2020-11-21
Authors: Shaker A Alomary; Ahmed J Al Madani; Wael A Althagafi; Izzeldin F Adam; Omneya E Elsherif; Aljoharah A Al-Abdullaah; Hamdan Al-Jahdali; Hani A Jokhdar; Saeed H Alqahtani; Mahmoud A Nahhas; Rasha A Alfawaz Journal: World Allergy Organ J Date: 2022-01-10 Impact factor: 4.084
Authors: Jamil M A S Obaid; Waheed A M Ali; Antar F A M Al-Badani; Zakaria M Damag; Tariq A Aziz; Yosef M Al-Ansi; Khawla A Sadek Journal: Eur J Med Res Date: 2022-03-03 Impact factor: 2.175
Authors: Anan Al Jabri; Ruqaiya Al Hinai; Ruth Balaji; Sharifa Al Harrasi; Deepali S Jaju; Hajar Al Rajaibi Journal: Sultan Qaboos Univ Med J Date: 2022-08-25